David D Tarazona

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Signaling Pathway

Respiratory Syndrome Coronavirus

Capillary Electrophoresis

Top Venues

Molecular genetics & genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pia V Sodhi, Francoise Sidime, David D Tarazona, Faviola Valdivia, Kelly S Levano
A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets. Vaccines 11 (1) (2022)
Pia V Sodhi, Francoise Sidime, David D Tarazona, Faviola Valdivia, Kelly S Levano
A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets. Vaccines 11 (1) (2022)
Pia V Sodhi, Francoise Sidime, David D Tarazona, Faviola Valdivia, Kelly S Levano
A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets. Vaccines 11 (1) (2022)
Luis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, Silvia Capristano, Roberto Zegarra Chapoñan, Cesar Sanchez, Velia M Yufra-Picardo, Eduardo Martín Tarazona Santos, Cesar Ugarte-Gil, Heinner Guio
NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients. Molecular genetics & genomic medicine 10 (8) (2022)
Pia V Sodhi, Francoise Sidime, David D Tarazona, Faviola Valdivia, Kelly S Levano
A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets. Vaccines 11 (1) (2022)
Kelly S Levano, Luis Jaramillo-Valverde, David D Tarazona, Cesar Sanchez, Silvia Capristano, Tania Vásquez-Loarte, Lely Solari, Alberto Mendoza-Ticona, Alonso Ricardo Soto-Tarazona, Christian Rojas, Roberto Zegarra Chapoñan, Heinner Guio
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients. Molecular genetics & genomic medicine 9 (10) (2021)